Survodutide
Metabolic / GLP-1 Research
$77.99 $122.99Price range: $77.99 through $122.99
Survodutide – an investigational dual glucagon/GLP-1 receptor agonist studied for metabolic, weight and liver research. Choose 5mg or 10mg.
Specifications
| Form | Lyophilized powder |
|---|---|
| Purity | >99% (third-party lab tested) |
| Typical dose | 2 mg weekly (reference) |
| Reconstitute | 2 mL bacteriostatic water |
| Application | Laboratory research use only |
Reconstitution calculator
Work out concentration, draw volume, and doses per vial. For laboratory research planning only.
How to read it: on a standard U-100 insulin syringe, 100 IU = 1 ml. The middle figure is the line to draw to. Always confirm against the research protocol. Products are sold for laboratory research use only, not for human consumption.
Description
Survodutide is an investigational dual glucagon/GLP-1 receptor agonist studied for metabolic, weight-reduction and liver-related research - adding glucagon-receptor action to the incretin pathway. Available in 5mg and 10mg.
Why it stands out
- Dual agonism: glucagon receptor + GLP-1 receptor in research models
- Studied for body-weight and glucose-handling endpoints
- Glucagon arm studied for energy expenditure and hepatic lipid metabolism
- Select your dosage below - 5mg or 10mg, third-party tested to >99% purity
Supplied as lyophilised powder, >99% purity, third-party lab-tested with a certificate of analysis on every batch. For laboratory and research use only — not for human or animal consumption.






Reviews
There are no reviews yet.